Abstract
The liver is a crucial organ regarding metabolic, immune and homeostatic regulation. Chronic and acute liver diseases, congenital or behavioral, accounts for approximately 2 million deaths per year. The only therapeutic options to severe liver diseases are partial or total liver transplantation. Hepatic tissue engineering, allied to human induced pluripotent stem cells (hiPSCs) technology…